Key Findings
- Across 29 cohorts (2,358 participants), selenium supplementation was associated with a significant reduction in thyroid peroxidase antibodies (TPOAb; SMD −0.96, 95% CI −1.36 to −0.56).
- Selenium was also associated with lower TSH and reduced oxidative-stress markers, independent of whether participants were on thyroid hormone replacement.
- TPOAb is a biomarker of autoimmune activity; reducing it has not been clearly shown to change clinical thyroid function or the need for medication.
- Heterogeneity between trials was high, and benefit may depend on a person's baseline selenium status.